Hexima Limited (HXL.XA)

0.0170 0.0000 (0.00%) At close: 03:33PM AEDT

Hexima Limited

C/-Acclime
Level 3, 62 Lygon Street
Carlton, VIC 3053
Australia
61 3 9824 5254
https://hexima.com.au

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Geoffrey Paul Kempler B.Sc.	MD & Chairman	47.3k	N/A	1955
Ms. Helen Molloy	Financial Controller	224.24k	N/A	N/A
Prof. Marilyn A. Anderson A.O., AO, B.Sc., BSc (Hons), FAA, FAICD, FT	Chief Science Officer	48.63k	N/A	1951
Dr. Neil Forrester	Vice President of Business Development	N/A	N/A	N/A
Dr. Nancy Sacco Ph.D.	Chief Development Officer	175.25k	N/A	N/A
Ms. Leanne Ralph AAICD, ACIS, BBus	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.

Corporate governance

Hexima Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.